Rates of Inhibitor development in previously untreated patients with severe hemophilia A treated with plasma-derived or recombinant factor VIII: no proof of difference or proof of no difference?
HTA Unit, ESTAV Toscana Centro, Regional Health Service, Firenze, Italy.
Andrea
A
Messori
HTA Unit, ESTAV Toscana Centro, Regional Health Service, Firenze, Italy.
Valeria
V
Fadda
HTA Unit, ESTAV Toscana Centro, Regional Health Service, Firenze, Italy.
Dario
D
Maratea
HTA Unit, ESTAV Toscana Centro, Regional Health Service, Firenze, Italy.
Sabrina
S
Trippoli
D005169:Factor VIII / Q000009:adverse effects*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans
D005169:Factor VIII